Answers are grounded in this paper and cite their sources.
A national survey highlights variability in 177Lu-DOTATATE therapy practices across UK health centres, suggesting a need for unified guidelines.
This survey demonstrates variation in the practical aspects and implementation of [177Lu]-DOTATATE therapy in the UK. Variability in behavioural restrictions highlights the need for clear national guidance on performing risk assessments for PRRT, to ensure a consistent patient experience. Free-text responses, particularly those relating to administration methods and incident learning, demonstrate the range of experiences across centres and the potential value of shared learning.
No takes yet. Share an insight, caveat, or question.
Houghton et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: